Tag: Drug Import

NMPA suspended the importation, sales and use of ABRAXANE®

The marketing agent for ABRAXANE® (nanoparticle albumin-bound paclitaxel), an immuno-oncology medication, in China has announced that the China National Medical Products Administration (NMPA) suspende...

Russian Senator Proposed to Make Unlimited Registration Term of Effective Imported Drugs

State Duma senator, chairman of the subcommittee on drug circulation, development of the pharmaceutical and medical industry of the State Duma committee on health protection Alexander Petrov proposed ...

FDA Offered Rule on Drug Importation

The Office of Management and Budget (OMB) is now reviewing a proposed rulemaking from the US Food and Drug Administration (FDA) to allow certain medicines to be imported from Canada and other countrie...

Pakistan to Lift Ban on Drug Import from India

The government in Pakistan has partly lifted an import ban to allow life-saving drugs from India into the country. The Ministry of Commerce issued the Statutory Regulatory Order (SRO) after approval f...

Russia Imported Veterinary Products Worth 31.9 bln RUB in 1H19

Between January and June 2019, Russia imported 31.9 bln RUB worth of veterinary products (free circulation prices), which is in monetary terms (rubles) only 0.1% higher than that of the same period in...

FDA and HHS Outlines Pathways for Safe Importation of Certain Prescription Drugs

The U.S. Department of Health and Human Services (HHS) announced that HHS and the U.S. Food and Drug Administration (FDA) are publishing a Safe Importation Action Plan that outlines two potential path...

Results of FAS Head and Association of European Businesses’ Members Meeting

The Working Groups will help solve particular competition issues. A traditional meeting of Head of FAS, Igor Artemiev, with representatives of the Association of European Businesses focused on the ...

FDA Examining Programs for Overseeing Global Operations and International Affairs

Concerns about the quality and safety of the growing volume of medicines imported to the United States, pressure to set international policies for genome editing of other scientific developments and e...

Cooperation of Russia and Bangladesh

Russian Ambassador to Bangladesh Alexander Ignatov on Wednesday said Russian private sector is interested to invest in joint venture (JV) projects in Bangladesh. During his meeting with Foreign Min...

Vietnamese Pharma Opens for Import

It is now easier for foreign companies to join the Vietnamese pharmaceutical market, buoyed by recently-loosened business conditions regarding drug registration and imports. The Ministry of Health ...

EAEU opens pharma market for foreign manufacturers

Prospective entry into the market of the EAEU of foreign medicinal products registered according to the national procedures of the EAEU States were discussed by the Member of the Board.

The import of finished medicines to Russia exceeded 244 billion rubles in H1 2018

Year over year growth comparing to the same period in 2017 when calculating in rubles amounted to 2% for finished forms, the supply of bulk products increased by 22% for the year.

Import of pharma products to Azerbaijan increased by 36%

The import of pharmaceutical products to Azerbaijan in January-July 2018 amounted to $ 153 million 793.16 thousand in monetary terms, the State Customs Committee reported.

Russia increased imports of pharma products from non-CIS countries by 3.2%

In January-July 2018, Russia increased imports of goods from foreign countries by 11.9% to reach $ 120.67 billion, informed TASS with reference to the Federal Customs Service of Russia.

In January-May of this year, Russia imported medicines for 198.7 billion rubles

For the period January-May 2018, imports of finished dosage forms (FDF) to Russia amounted to 198.7 billion rubles (in prices of release for free circulation).

In Q1 2018 Russian imports of finished drugs fell by 7.9% in physical terms

During the first four months of 2018, the imports of finished medicinal products to Russia amounted to 156.1 billion rubles (in prices set for release for free circulation).